Towards Healthcare
Antacids Market Size, Trends & 3.30% CAGR Growth by 2034

Antacids Market Size to Capture USD 10.33 Billion by 2034

The antacids market is growing due to rising acid reflux and GERD cases from sedentary lifestyles, an aging population, and increased R&D for novel formulations. Widely used OTC, antacids neutralize stomach acid, offering quick relief for GERD, heartburn, and ulcers, driving global market demand.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Antacids Market Assessment

  • Overview
  • Global Antacids Market Size Value (US$) and Volume (Billion Tons), by Formulation Type (2021 – 2033)
    • Tablet
    • Liquid
    • Other
  • Global Antacids Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Gastroesophageal Reflux Disease
    • Heartburn
    • Indigestion
    • Others
  • Global Antacids Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Drug Store and Retail Pharmacy
    • Online Provider
  • Global Antacids Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East and Africa

North America Antacids Market Assessment

  • Overview
  • North America Antacids Market Size Value (US$) and Volume (Billion Tons), by Formulation Type (2021 – 2033)
    • Tablet
    • Liquid
    • Other
  • North America Antacids Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Gastroesophageal Reflux Disease
    • Heartburn
    • Indigestion
    • Others
  • North America Antacids Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Drug Store and Retail Pharmacy
    • Online Provider

Europe Antacids Market Assessment

  • Overview
  • Europe Antacids Market Size Value (US$) and Volume (Billion Tons), by Formulation Type (2021 – 2033)
    • Tablet
    • Liquid
    • Other
  • Europe Antacids Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Gastroesophageal Reflux Disease
    • Heartburn
    • Indigestion
    • Others
  • Europe Antacids Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Drug Store and Retail Pharmacy
    • Online Provider

Asia-Pacific Antacids Market Assessment

  • Overview
  • Asia-Pacific Antacids Market Size Value (US$) and Volume (Billion Tons), by Formulation Type (2021 – 2033)
    • Tablet
    • Liquid
    • Other
  • Asia-Pacific Antacids Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Gastroesophageal Reflux Disease
    • Heartburn
    • Indigestion
    • Others
  • Asia-Pacific Antacids Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Drug Store and Retail Pharmacy
    • Online Provider

Latin America Antacids Market Assessment

  • Overview
  • Latin America Antacids Market Size Value (US$) and Volume (Billion Tons), by Formulation Type (2021 – 2033)
    • Tablet
    • Liquid
    • Other
  • Latin America Antacids Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Gastroesophageal Reflux Disease
    • Heartburn
    • Indigestion
    • Others
  • Latin America Antacids Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Drug Store and Retail Pharmacy
    • Online Provider

Middle East and Africa Antacids Market Assessment

  • Overview
  • Middle East and Africa Antacids Market Size Value (US$) and Volume (Billion Tons), by Formulation Type (2021 – 2033)
    • Tablet
    • Liquid
    • Other
  • Middle East and Africa Antacids Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Gastroesophageal Reflux Disease
    • Heartburn
    • Indigestion
    • Others
  • Middle East and Africa Antacids Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Drug Store and Retail Pharmacy
    • Online Provider

Company Profiles

  • Bayer AG
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • GlaxoSmithKline Plc.
  • Takeda Pharmaceutical Company Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Dr Reddy's Laboratories Ltd.
  • Pfizer Inc.
  • Reckitt Benckiser Group Plc.
  • Cipla Ltd.
  • Alkem Laboratories Ltd.
  • Abbott Laboratories

Conclusion & Recommendations

  • Insight Code: 5079
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: November 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of experience specializing in the healthcare sector. His expertise spans various facets of healthcare, including market dynamics, emerging trends, regulatory changes, and technology-driven innovations. With a keen eye for detail and a deep understanding of the global healthcare landscape, Rohan has been instrumental in shaping actionable insights that guide healthcare organizations in making informed, data-driven decisions.

Rohan's extensive experience covers a wide range of healthcare segments, from pharmaceuticals and biotechnology to medical devices and digital health. He has worked on numerous projects that evaluate market potential, assess competitive landscapes, and identify growth opportunities in rapidly evolving sectors in the healthcare industry.

His analytical acumen and ability to synthesize complex data have made him a trusted advisor to healthcare companies, helping them navigate the challenges and opportunities within the healthcare ecosystem. Rohan is particularly passionate about how technology and innovation are reshaping healthcare delivery, and his reports provide valuable insights into the impact of digital transformation on patient care, outcomes, and cost-efficiency.

With a strong track record in healthcare market research, Rohan continues to contribute significantly to the advancement of the industry by delivering data-backed strategies and comprehensive market analysis.

FAQ's

The rise is attributed to factors like dietary habits and lifestyle changes. Consequently, the antacid market has grown is due prevalence of diseases to meet the increasing demand for treating the symptoms of acid reflux. The Aging Population is also responsible for Driving Demand for Antacids.

The major key players operating in the antacid market are Bayer AG, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Ltd., Sun Pharmaceutical Industries Ltd., Dr Reddys Laboratories Ltd., Pfizer Inc., Reckitt Benckiser Group Plc., Cipla Ltd., Alkem Laboratories Ltd., and Abbott Laboratories.

North America and Asia-Pacific are the leading region for the Global Antacid Market.

National Institute of Health, World Health Organisation, Centers for Disease Control and Prevention, American Journal of Health-System Pharmacy, USDA | Economical Research Services, ScienceDirect, Wolters Kluwer, MedlinePlus(.gov), International Journal of Research in Medical Sciences

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 515

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 515